BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Almasio PL, Babudieri S, Barbarini G, Brunetto M, Conte D, Dentico P, Gaeta GB, Leonardi C, Levrero M, Mazzotta F, Morrone A, Nosotti L, Prati D, Rapicetta M, Sagnelli E, Scotto G, Starnini G. Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates). Digestive and Liver Disease 2011;43:589-95. [DOI: 10.1016/j.dld.2010.12.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Tosti ME, Marceca M, Eugeni E, D'Angelo F, Geraci S, Declich S, Della Seta M, Ferrigno L, Marrone R, Pajno C, Pizzarelli S, Rosso A, De Ponte G, Mirisola C, Baglio G. Health assessment for migrants and asylum seekers upon arrival and while hosted in reception centres: Italian guidelines. Health Policy 2021;125:393-405. [PMID: 33461797 DOI: 10.1016/j.healthpol.2020.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
2 Fiore V, De Matteis G, Ranieri R, Saderi L, Pontali E, Muredda A, Ialungo AM, Caruso R, Madeddu G, Sotgiu G, Babudieri S. HCV testing and treatment initiation in an Italian prison setting: A step-by-step model to micro-eliminate hepatitis C. Int J Drug Policy. 2021;90:103055. [PMID: 33310637 DOI: 10.1016/j.drugpo.2020.103055] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
3 Okafor IM, Ugwu SO, Okoroiwu HU. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison. BMC Gastroenterol 2020;20:360. [PMID: 33126856 DOI: 10.1186/s12876-020-01504-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Kitala D, Klama-Baryła A, Kraut M, Łabuś W, Glik J, Kawecki M. The Causes for the Loss of Cellular Material at the Qualification Stage and the Influence of the Patient's Flora on Culture Infection. Transplant Proc 2020;52:2231-5. [PMID: 32474001 DOI: 10.1016/j.transproceed.2020.02.112] [Reference Citation Analysis]
5 Lotfi T, Itani MI, Howeiss P, Kilzar L, Rizk NA, Akl EA. Practice guidelines on migrants' health: assessment of their quality and reporting. Health Qual Life Outcomes 2020;18:125. [PMID: 32380997 DOI: 10.1186/s12955-020-01363-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Masarone M, Caruso R, Aglitti A, Izzo C, De Matteis G, Attianese MR, Pagano AM, Persico M. Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program. Dig Liver Dis 2020;52:541-6. [PMID: 32234417 DOI: 10.1016/j.dld.2020.02.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
7 Stasi C, Silvestri C, Voller F. Hepatitis B vaccination and immunotherapies: an update. Clin Exp Vaccine Res. 2020;9:1-7. [PMID: 32095435 DOI: 10.7774/cevr.2020.9.1.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
8 Agbata EN, Padilla PF, Agbata IN, Armas LH, Solà I, Pottie K, Alonso-Coello P. Migrant Healthcare Guidelines: A Systematic Quality Assessment. J Immigr Minor Health 2019;21:401-13. [PMID: 29785690 DOI: 10.1007/s10903-018-0759-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
9 Puga MAM, Bandeira LM, Pompilio MA, Rezende GR, Soares LS, de Castro VOL, Tanaka TSO, Cesar GA, de Oliveira SMDVL, Teles SA, Yassuda RTS, Weis-Torres SMDS, Basílio SF, Croda J, Motta-Castro ARC. Screening for HBV, HCV, HIV and syphilis infections among bacteriologically confirmed tuberculosis prisoners: An urgent action required. PLoS One 2019;14:e0221265. [PMID: 31437184 DOI: 10.1371/journal.pone.0221265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
10 Stasi C, Monnini M, Cellesi V, Salvadori M, Marri D, Ameglio M, Gabbuti A, Di Fiandra T, Voller F, Silvestri C. Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study. Vaccine 2019;37:1412-7. [PMID: 30733091 DOI: 10.1016/j.vaccine.2019.01.049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
11 Wright N, Reimer J, Somaini L, Roncero C, Maremmani I, Simon N, Krajci P, Littlewood R, D'Agnone O, Alho H, Rolland B. Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model. Eur J Gastroenterol Hepatol 2017;29:1206-14. [PMID: 28914697 DOI: 10.1097/MEG.0000000000000962] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
12 Cheng CH, Lin CC, Chen HL, Lin IT, Wu CH, Lee YK, Bair MJ. Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection. PLoS One 2018;13:e0191799. [PMID: 29389957 DOI: 10.1371/journal.pone.0191799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Andreoni M, Babudieri S, Bruno S, Colombo M, Zignego AL, Di Marco V, Di Perri G, Perno CF, Puoti M, Taliani G, Villa E, Craxì A. Current and future challenges in HCV: insights from an Italian experts panel. Infection 2018;46:147-63. [PMID: 29098647 DOI: 10.1007/s15010-017-1093-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
14 Hermetet C, Dubois F, Gaudy-Graffin C, Bacq Y, Royer B, Gaborit C, D'Alteroche L, Desenclos JC, Roingeard P, Grammatico-Guillon L. Continuum of hepatitis C care in France: A 20-year cohort study. PLoS One 2017;12:e0183232. [PMID: 28850623 DOI: 10.1371/journal.pone.0183232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Carvalhana SC, Leitão J, Alves AC, Bourbon M, Cortez-Pinto H. Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups. Eur J Gastroenterol Hepatol 2016;28:640-4. [PMID: 26866523 DOI: 10.1097/MEG.0000000000000608] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
16 Stasi C, Silvestri C, Voller F. Emerging Trends in Epidemiology of Hepatitis B Virus Infection. J Clin Transl Hepatol 2017;5:272-6. [PMID: 28936408 DOI: 10.14218/JCTH.2017.00010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
17 Sanarico N, D'Amato S, Bruni R, Rovetto C, Salvi E, Di Zeo P, Chionne P, Madonna E, Pisani G, Costantino A, Equestre M, Tosti ME, Cenci A, Maggiorella MT, Sernicola L, Pontali E, Pansera A, Quattrocchi R, Carbonara S, Signorile F, Surace LA, Federzoni G, Garlassi E, Starnini G, Monarca R, Babudieri S, Rapicetta M, Pompa MG, Caraglia A, Ensoli B, Ciccaglione AR, Buttò S. Correlates of infection and molecular characterization of blood-borne HIV, HCV, and HBV infections in HIV-1 infected inmates in Italy: An observational cross-sectional study. Medicine (Baltimore) 2016;95:e5257. [PMID: 27858889 DOI: 10.1097/MD.0000000000005257] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
18 Ranieri R, Starnini G, Carbonara S, Pontali E, Leo G, Romano A, Panese S, Monarca R, Prestileo T, Barbarini G, Babudieri S; SIMSPe Group. Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel. Infection. 2017;45:131-138. [PMID: 28025726 DOI: 10.1007/s15010-016-0973-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
19 Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH. Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review. J Subst Abuse Treat 2017;72:117-25. [PMID: 27394070 DOI: 10.1016/j.jsat.2016.06.009] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
20 Zampino R, Coppola N, Sagnelli C, Di Caprio G, Sagnelli E. Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment. World J Hepatol 2015; 7(21): 2323-2330 [PMID: 26413221 DOI: 10.4254/wjh.v7.i21.2323] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
21 Smyth DJ, Webster D, Barrett L, MacMillan M, McKnight L, Schweiger F. Transitioning to highly effective therapies for the treatment of chronic hepatitis C virus infection: a policy statement and implementation guideline. Can J Gastroenterol Hepatol 2014;28:529-34. [PMID: 25390613 DOI: 10.1155/2014/109046] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
22 Monge-Maillo B, López-Vélez R, Norman FF, Ferrere-González F, Martínez-Pérez Á, Pérez-Molina JA. Screening of imported infectious diseases among asymptomatic sub-Saharan African and Latin American immigrants: a public health challenge. Am J Trop Med Hyg 2015;92:848-56. [PMID: 25646257 DOI: 10.4269/ajtmh.14-0520] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 6.4] [Reference Citation Analysis]
23 Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat. 2014;21 Suppl 1:60-89. [PMID: 24713006 DOI: 10.1111/jvh.12249] [Cited by in Crossref: 139] [Cited by in F6Publishing: 137] [Article Influence: 17.4] [Reference Citation Analysis]
24 Negro F. Epidemiology of hepatitis C in Europe. Dig Liver Dis. 2014;46 Suppl 5:S158-S164. [PMID: 25453870 DOI: 10.1016/j.dld.2014.09.023] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 6.6] [Reference Citation Analysis]
25 Zanini B, Benini F, Pigozzi MG, Furba P, Giacò E, Cinquegrana A, Fasoli M, Lanzini A. Addicts with chronic hepatitis C: difficult to reach, manage or treat? World J Gastroenterol. 2013;19:8011-8019. [PMID: 24307794 DOI: 10.3748/wjg.v19.i44.8011.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Monge-maillo B, Norman F, Pérez-molina J, Navarro M, Díaz-menéndez M, López-vélez R. Travelers visiting friends and relatives (VFR) and imported infectious disease: Travelers, immigrants or both? A comparative analysis. Travel Medicine and Infectious Disease 2014;12:88-94. [DOI: 10.1016/j.tmaid.2013.07.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
27 Zanini B, Benini F, Pigozzi MG, Furba P, Giacò E, Cinquegrana A, Fasoli M, Lanzini A. Addicts with chronic hepatitis C: Difficult to reach, manage or treat? World J Gastroenterol 2013; 19(44): 8011-8019 [PMID: 24307794 DOI: 10.3748/wjg.v19.i44.8011] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
28 Iacomi F, Iannicelli G, Franceschini A, Migliorisi P, Rosati S, Piselli P, Scognamiglio P, De Carli G, Marcellini S, Palmieri F. HCV infected prisoners: should they be still considered a difficult to treat population? BMC Infect Dis 2013;13:374. [PMID: 23945309 DOI: 10.1186/1471-2334-13-374] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
29 Harris M, Rhodes T. Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors. Harm Reduct J 2013;10:7. [PMID: 23651646 DOI: 10.1186/1477-7517-10-7] [Cited by in Crossref: 147] [Cited by in F6Publishing: 161] [Article Influence: 16.3] [Reference Citation Analysis]
30 Dana D, Zary N, Peyman A, Behrooz A. Risk prison and hepatitis B virus infection among inmates with history of drug injection in Isfahan, Iran. ScientificWorldJournal 2013;2013:735761. [PMID: 23737725 DOI: 10.1155/2013/735761] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
31 Padovese V, Egidi AM, Melillo TF, Farrugia B, Carabot P, Didero D, Costanzo G, Mirisola C. Prevalence of latent tuberculosis, syphilis, hepatitis B and C among asylum seekers in Malta. J Public Health (Oxf). 2014;36:22-27. [PMID: 23559596 DOI: 10.1093/pubmed/fdt036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
32 Perrett SE, Craine N, Lyons M. Developing blood borne virus services across prisons in Wales, UK. Intl Jnl of Prisoner Health 2013;9:31-9. [DOI: 10.1108/17449201311310788] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
33 Ross RS, Stambouli O, Grüner N, Marcus U, Cai W, Zhang W, Zimmermann R, Roggendorf M. Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification. Virol J. 2013;10:72. [PMID: 23497102 DOI: 10.1186/1743-422x-10-72] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
34 Ross RS, Stambouli O, Grüner N, Marcus U, Cai W, Zhang W, Zimmermann R, Roggendorf M. Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification. Virol J. 2013;10:72. [PMID: 23497102 DOI: 10.1016/j.antiviral.2011.12.011] [Cited by in Crossref: 92] [Cited by in F6Publishing: 93] [Article Influence: 10.2] [Reference Citation Analysis]
35 Fasano M, Saracino A, Carosi G, Mazzotta F, Marino N, Sagnelli E, Gaeta GB, Angarano G, Verucchi G, Bellissima P, Angeletti C, Santantonio T. Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study. Infection 2013;41:53-9. [PMID: 23264094 DOI: 10.1007/s15010-012-0384-9] [Reference Citation Analysis]
36 Stroffolini T, D’Egidio PF, Aceti A, Filippini P, Puoti M, Leonardi C, Almasio PL. Hepatitis C virus infection among drug addicts in Italy. J Med Virol. 2012;84:1608-1612. [PMID: 22930509 DOI: 10.1002/jmv.23370] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
37 Fasano M, Saracino A, Carosi G, Mazzotta F, Marino N, Sagnelli E, Gaeta GB, Angarano G, Verucchi G, Bellissima P. Hepatitis B and immigrants: a SIMIT multicenter cross-sectional study. Infection. 2013;41:53-59. [PMID: 23264094 DOI: 10.1007/s15010-012-0384-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
38 Ward JW, Rein DB, Smith BD. Data to guide the "test and treat era" of hepatitis C. Gastroenterology 2012;143:887-9. [PMID: 22922026 DOI: 10.1053/j.gastro.2012.08.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
39 Babudieri S, Soddu A, Murino M, Molicotti P, Muredda AA, Madeddu G, Fois AG, Zanetti S, Pirina P, Mura MS. Tuberculosis screening before anti-hepatitis C virus therapy in prisons. Emerg Infect Dis. 2012;18:689-691. [PMID: 22469015 DOI: 10.3201/eid1804.111016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]